中国医师杂志
中國醫師雜誌
중국의사잡지
JOURNAL OF CHINESE PHYSICIAN
2013年
9期
1153-1157
,共5页
尚云峰%田道法%Yang PC
尚雲峰%田道法%Yang PC
상운봉%전도법%Yang PC
鼻咽肿瘤/中药疗法%鼻咽肿瘤/病理学%细胞运动%细胞骨架
鼻嚥腫瘤/中藥療法%鼻嚥腫瘤/病理學%細胞運動%細胞骨架
비인종류/중약요법%비인종류/병이학%세포운동%세포골가
Nasopharyngeal neoplasms/ZHONG YAO LIAO FA%Nasopharyngeal neoplasms/pathology%Cell movement%Cytoskeleton
目的 探讨益气解毒方对CNE2Z鼻咽癌细胞迁徙运动潜能的影响及其与细胞骨架蛋白系统表达活性的关系.方法 以正常大鼠血浆为空白对照,以益气解毒方大鼠血浆为干预因素,采用划痕法评价含药血浆对靶细胞CNE2Z鼻咽癌细胞迁徙运动潜能的影响,以扫描电镜观察干预前后靶细胞伪足形态特征,免疫组化SABC法检测β-tubulin、F-actin、p-Ezrin、Rac1表达活性,RT-PCR法检测p-Ezrin mRNA转录活性,评价靶细胞迁徙运动潜能变化与细胞骨架蛋白系统表达活性的关系及其对益气解毒方干预作用的反应性.结果 益气解毒方对CNE2Z鼻咽细胞的迁徙运动潜能显示抑制效应,在IC50浓度时,迁徙距离为(25.80 ±8.07) μm,抑制率为46.59%;靶细胞表现伪足变短小,伸展长度变短;β-tubulin、F-actin、p-Ezrin、Rac-1蛋白表达受抑制,图像灰度值分别为(0.857±0.059,0.900±0.040,0.812±0.050,0.785±0.022),与对照组的差异有统计学意义(P<0.01);p-Ezrin mRNA表达水平呈现同样变化趋势.结论 益气解毒方对CNE2Z细胞的迁徙运动潜能发挥抑制效应,伴随以靶细胞骨架蛋白系统生物活性的降低,细胞伪足伸展抑制.
目的 探討益氣解毒方對CNE2Z鼻嚥癌細胞遷徙運動潛能的影響及其與細胞骨架蛋白繫統錶達活性的關繫.方法 以正常大鼠血漿為空白對照,以益氣解毒方大鼠血漿為榦預因素,採用劃痕法評價含藥血漿對靶細胞CNE2Z鼻嚥癌細胞遷徙運動潛能的影響,以掃描電鏡觀察榦預前後靶細胞偽足形態特徵,免疫組化SABC法檢測β-tubulin、F-actin、p-Ezrin、Rac1錶達活性,RT-PCR法檢測p-Ezrin mRNA轉錄活性,評價靶細胞遷徙運動潛能變化與細胞骨架蛋白繫統錶達活性的關繫及其對益氣解毒方榦預作用的反應性.結果 益氣解毒方對CNE2Z鼻嚥細胞的遷徙運動潛能顯示抑製效應,在IC50濃度時,遷徙距離為(25.80 ±8.07) μm,抑製率為46.59%;靶細胞錶現偽足變短小,伸展長度變短;β-tubulin、F-actin、p-Ezrin、Rac-1蛋白錶達受抑製,圖像灰度值分彆為(0.857±0.059,0.900±0.040,0.812±0.050,0.785±0.022),與對照組的差異有統計學意義(P<0.01);p-Ezrin mRNA錶達水平呈現同樣變化趨勢.結論 益氣解毒方對CNE2Z細胞的遷徙運動潛能髮揮抑製效應,伴隨以靶細胞骨架蛋白繫統生物活性的降低,細胞偽足伸展抑製.
목적 탐토익기해독방대CNE2Z비인암세포천사운동잠능적영향급기여세포골가단백계통표체활성적관계.방법 이정상대서혈장위공백대조,이익기해독방대서혈장위간예인소,채용화흔법평개함약혈장대파세포CNE2Z비인암세포천사운동잠능적영향,이소묘전경관찰간예전후파세포위족형태특정,면역조화SABC법검측β-tubulin、F-actin、p-Ezrin、Rac1표체활성,RT-PCR법검측p-Ezrin mRNA전록활성,평개파세포천사운동잠능변화여세포골가단백계통표체활성적관계급기대익기해독방간예작용적반응성.결과 익기해독방대CNE2Z비인세포적천사운동잠능현시억제효응,재IC50농도시,천사거리위(25.80 ±8.07) μm,억제솔위46.59%;파세포표현위족변단소,신전장도변단;β-tubulin、F-actin、p-Ezrin、Rac-1단백표체수억제,도상회도치분별위(0.857±0.059,0.900±0.040,0.812±0.050,0.785±0.022),여대조조적차이유통계학의의(P<0.01);p-Ezrin mRNA표체수평정현동양변화추세.결론 익기해독방대CNE2Z세포적천사운동잠능발휘억제효응,반수이파세포골가단백계통생물활성적강저,세포위족신전억제.
Objective To investigate the intervening effect of Qi-Boosting Toxin-Resolving Formula (QBTRF) on the migration potentiality of nasopharyngeal carcinoma (NPC) cells and its association with the expressive activities of cellular skeletal protein system based on an experimental study in vitro.Methods In this study,QBTRF medicine-containing plasma of rats was taken as the intervening factor to treat the targeted NPC cells of CEN2Z for evaluating the correlation of changes in migrating potentiality of CEN2Z cells with expression activities of cellular skeletal protein system and their response to the pharmacological intervening effects of QBTRF,compared with the normal plasma of rats as the control.Here,scratching test was taken to evaluate the migration potentiality of targeting cells,immunohistochemical SABC assays were used to determine the expression activities of β-tubulin,F-actin,p-Ezrin and Rac1,which were taken as the typical indicators of cellular skeletal protein system.Scanning electron microscopy was selected to observe the changes in cellular pseudopodia.Reverse transcription-polymerase chain reaction (RT-PCR) procedure was used to detect the transcriptional activity of p-Ezrin mRNA.Results QBTRF showed a very significant inhibitory effect on the migration potentiality of CEN2Z cells,with its migration distance reduced to (25.80 ±8.07) μm and an inhibitory rate reached at 46.59% at the concentration of IC50.Meanwhile,their cellular pseudopodia was shortened significantly,accompanied with very reduced extension length.Obviously decreased were the expression activities of β-tubulin,F-actin,p-Ezrin and Rac1 proteins,with their figure gray values being 0.857 ±0.059,0.900 ±0.040,0.812 ±0.050 and 0.785 ±0.022,respectively,with statistical significance compared with controls (P <0.01).Also seen was the same tendency of transcriptional level of p-Ezrin mRNA when cells cultured with QBTRE medicines-containing plasma together.Conclusions QBTRF holds significantly inhibitory effect on the migration potentiality of CEN2Z NPC cells.This kind of inhibitory effect may be associated with the reduced biological activity of cellular skeletal protein system and corresponding cellular pseudopodia changes.